Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Series
Commentary
Editorial
Invited Article
Original Article
Review Article
Short Communication
Special Issue on COVID-19 & ART
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Series
Commentary
Editorial
Invited Article
Original Article
Review Article
Short Communication
Special Issue on COVID-19 & ART
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Series
Commentary
Editorial
Invited Article
Original Article
Review Article
Short Communication
Special Issue on COVID-19 & ART
View/Download PDF

Translate this page into:

Editorial
2025
:6;
8
doi:
10.25259/JRHM_5_2025

Advancing reproductive healthcare medicine

Department of Gynaecology, RiSAA IVF, Delhi, India.
Author image

*Corresponding author: Rita Bakshi, Department of Gynaecology, RiSAA IVF, Delhi, India. ritabakshi.ifc@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Bakshi R. Advancing reproductive healthcare medicine. J Reprod Healthc Med. 2025;6:8. doi: 10.25259/JRHM_5_2025

It is an immense honor to represent the Indian Society for the Study of Reproduction and Fertility, an esteemed society committed to setting ethical standards for clinical practice and research in India. This prestigious position comes with significant responsibility, compelling us to reflect on the Academy’s rich history and ongoing initiatives while striving to set new benchmarks for the medical fraternity.

One of the key objectives in this journey is to further elevate the standing of our official journal, Journal of Reproductive Healthcare and Medicine (JRHM). Our vision is to establish JRHM as a highly reputed, indexed, and sought-after journal for students, researchers, and academicians, both within India and internationally. The journal has consistently published diverse and impactful content, addressing the latest advancements like engineered immune cell-based therapy,[1] and uses of autologous platelet-rich plasma[2] in reproductive medicine and also covering the research in allied medical disciplines like nano-biosensor in breast cancer,[3] prostate cancer in India,[4] role of fibroblast growth factor 8 in different cancers,[5] and many more.

As specialists in Reproductive Medicine, it is encouraging to witness the journal fostering scientific discussions on critical and emerging topics in our field. Recent publications have highlighted groundbreaking advancements, including the impact of assisted reproductive technologies (ART) on perinatal health, evolving trends in oocyte cryopreservation, the burden of genital tuberculosis in infertility,[6] the role of intrauterine insemination in improving pregnancy outcomes,[7] future directions in genetic and mutational research in assisted reproduction,[8,9] and advancements in embryology studies.[10,11] These contributions underscore the increasing focus on reproductive medicine and stand as a testament to India’s dedication to advancing scientific innovation in this vital field.

Beyond reproductive medicine, JRHM has featured a diverse range of clinical and research topics that appeal to healthcare professionals across various specialties like the impact of COVID-19 on the maternal and peri-natal outcome,[12,13] the role of genes in polycystic ovarian syndrome (PCOS)[14] and detailed research on menopausal health.[15,16] Recent publications have explored advancements in infertility management, alongside comprehensive review articles on reproductive medicine and obstetrics. This groundbreaking work highlights the significance of interdisciplinary collaboration in medicine and reinforces the journal’s commitment to sharing knowledge that shapes future clinical practices.

JRHM also serves as a platform for young researchers and clinicians to share their insights through extensive review articles. These reviews not only track the evolution of clinical practice but also serve as valuable educational resources for medical students and budding specialists. Notable reviews have explored the implications of hormonal therapy in reproductive aging, the genetic basis of recurrent pregnancy loss, and the intersection of immunology and infertility treatment. These reviews equip our readers with a deeper understanding of emerging concepts and evolving therapeutic approaches.

Furthermore, JRHM actively engages with broader healthcare concerns that extend beyond direct patient care. Important discussions have included the psychosocial aspects of infertility, ethical considerations in ART, and the integration of yoga and mindfulness in improving reproductive outcomes. By addressing such themes, JRHM enriches academic discourse while contributing meaningfully to societal well-being.

On the molecular research front, the journal has featured groundbreaking studies, including genetic predisposition to endometriosis, biomarkers for embryo viability, and innovations in preimplantation genetic testing. These intricate studies highlight the robust scientific advancements taking place within Indian research institutions and reinforce our nation’s growing prominence in reproductive and molecular medicine.

The JRHM stands as a distinguished multidisciplinary platform, publishing high-caliber content that spans clinical, social, and academic spheres. It serves as an essential resource for the medical community, offering valuable insights to students, researchers, and clinicians alike. We take immense pride in the journal’s progress and extend our sincere congratulations to the Editor-in-Chief, Prof. N. K. Lohiya, along with the dedicated editorial team and reviewers, whose collective efforts have significantly strengthened the journal’s influence.

We wholeheartedly appreciate our esteemed authors; whose invaluable contributions continue to drive the journal’s success. We encourage researchers and clinicians in reproductive medicine and allied fields to actively contribute their pioneering work, ensuring that JRHM remains at the forefront of medical science in the years to come. Finally, we also extend our deep gratitude to our publishers, Scientific Scholar, for their steadfast commitment to delivering high-quality publications to our readership. Their production output is the extremely efficient, whereas their strategic publishing approach is really impressive. Together, we envision that JRHM will become the leading journal in the field of reproductive clinical sciences not only in India but also in South-East Asia ahead.

Dr. Rita Bakshi,

Associate Editor

Journal of Reproductive Healthcare and Medicine

References

  1. , , , , . Engineered immune cell-based therapeutics for female reproductive tract cancers: Advances and future prospects. J Reprod Healthc Med. 2024;5:14.
    [CrossRef] [Google Scholar]
  2. , , , , . Autologous platelet-rich plasma as a potential new approach in the endometrial response during in vitro fertilization cycle: A pilot study. J Reprod Healthc Med. 2024;5:3.
    [CrossRef] [Google Scholar]
  3. , , . Quantum imaging-based nanobiosensors: Pioneering point-of-care approach for early diagnosis of environmental-linked breast cancer. J Reprod Healthc Med. 2024;5:9.
    [CrossRef] [Google Scholar]
  4. , , , , , , et al. Prostate cancer in India: Current perspectives and the way forward. J Reprod Healthc Med. 2023;4:8.
    [CrossRef] [Google Scholar]
  5. , , . Role of fibroblast growth factor 8 in different cancers. J Reprod Healthc Med. 2023;4:5.
    [CrossRef] [Google Scholar]
  6. , , , , , , et al. Genital tuberculosis: A silent contributor to infertility and adverse pregnancy outcomes. J Reprod Healthc Med. 2024;5:17.
    [CrossRef] [Google Scholar]
  7. , , , . Outcome of intrauterine insemination in couples with unexplained or male factor infertility at national referral hospital of Bhutan. J Reprod Healthc Med. 2024;5:1.
    [CrossRef] [Google Scholar]
  8. , , , . Penetrance of missense mutation of OR2AT4 and OR9G1/9 gene polymorphism increases risk factor in azoospermic patients. J Reprod Healthc Med. 2023;4:7.
    [CrossRef] [Google Scholar]
  9. , , , , . Identification of testis derived differentially expressed spermatogenic microRNAs in idiopathic hypospermatogenesis. J Reprod Healthc Med. 2025;6:4.
    [CrossRef] [Google Scholar]
  10. , , , , . Progesterone supplemented uterine epithelial cell co-culture improves in vitro quality embryo production in buffalo. J Reprod Healthc Med. 2024;5:10.
    [CrossRef] [Google Scholar]
  11. , , , , , , et al. Cyclic nucleotides regulate oocyte meiotic maturation and quality in mammals. J Reprod Healthc Med. 2020;1:1.
    [CrossRef] [Google Scholar]
  12. , , , , , . Pregnancy management in coronavirus disease-challenges in developing countries. J Reprod Healthc Med. 2021;2:18.
    [CrossRef] [Google Scholar]
  13. , , , , . Impact of COVID-19 pandemic on maternal and neonatal outcomes: A narrative review and evidence from the PregCovid registry. J Reprod Healthc Med. 2023;4:2.
    [CrossRef] [Google Scholar]
  14. , , , , , , et al. Role of genetic, environmental, and hormonal factors in the progression of PCOS: A review. J Reprod Healthc Med. 2022;3:3.
    [CrossRef] [Google Scholar]
  15. , , . Menopausal hormone-replacement therapy and breast cancer risk: An updated and simplified view. J Reprod Healthc Med. 2022;3:4.
    [CrossRef] [Google Scholar]
  16. , , , , . Key determinants of postmenopausal osteoporosis: A mini-review of current insights. J Reprod Healthc Med. 2024;5:12.
    [CrossRef] [Google Scholar]

Fulltext Views
194

PDF downloads
7
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections